Endothelix is a cardiovascular device company. Our first product, VENDYS®, is FDA cleared, reimbursable and is generating revenue today.
Endothelix is a cardiovascular diagnostic company with an FDA cleared device (VENDYS®), a pipeline, and a pioneering team. Technology licensed from the Texas Heart Institute detects Endothelial Dysfunction, an early biomarker of CVD and an indicator of response to drug therapies. A simple, non-invasive, reimbursable (~$175) test done in a doctor’s office We are seeking series B investors to expand our sales team and conduct a new clinical trial.